pidilizumab

What Pfizer Gets in Its $14 Billion Medivation Deal
Motley Fool
Tue, 08/23/16 - 10:02 am
Pfizer
Medivation
M&A
Xtandi
prostate cancer
talazoparib
pidilizumab
Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game changer
Yahoo/Business Insider
Mon, 08/22/16 - 11:45 am
Pfizer
Medivation
M&A
Sanofi
Xtandi
prostate cancer
pidilizumab
talazoparib
Medivation Destined To Become A Biotech Behemoth As Low-Risk Pipeline Expands
Seeking Alpha
Wed, 09/2/15 - 12:43 pm
talazoparib
Medivation
Xtandi
pidilizumab